Brian Evans

5 days ago | cnbc.com | Brian Evans

Analysts on Wall Street are especially optimistic on a handful of stocks heading into the second half of the year. Equities have been volatile for much of the first half of 2025, as President Donald Trump's tariffs simultaneously sparked investor concern over a potential U.S. recession and higher inflation. Worries over the size of the federal deficit and increasing debt arose from the president's tax bill working its way through Congress.

1 week ago | cnbc.com | Brian Evans

Major defense stocks can still benefit even if President Donald Trump 's "Golden Dome" project fails, according to Bernstein. The prospect of completing the missile defense system before the end of Trump's term in 2029, which the president has cited as his goal for the project, is highly unlikely, analyst Douglas Harned wrote in a note to clients last week. However, that doesn't mean the effort won't drive business for the defense industry, he said.

1 week ago | cnbc.com | Brian Evans

Traders work on the floor of the New York Stock Exchange on April 2, 2025. NYSEStock futures were lower ahead of Friday's session, with investors monitoring conflict in the Middle East between Iran and Israel, and potential direct U.S. involvement. Futures tied to the Dow Jones Industrial Average slipped 154 points, or 0.3%. Nasdaq 100 futures ticked down 0.2%, while S&P 500 futures fell 0.2%. Regular trading was closed in the U.S. on Thursday for the Juneteenth holiday.

1 week ago | cnbc.com | Brian Evans

Check out the companies making headlines in midday trading. Steel stocks– Shares of steel producer Nucor jumped more than 3%. The company issued rosy guidance for its second-quarter earnings, calling for $2.55 to $2.65 per share, while FactSet consensus estimates sought $2.36 per share. In contrast, Steel Dynamics' guidance fell short of Wall Street's estimates, ranging from $2.00 to $2.04 per share, while analysts were looking for $2.73 per share. The stock slipped 1%.

1 week ago | cnbc.com | Brian Evans

Check out the companies making headlines in premarket trading. Sunrun — Shares fell nearly 2% following a downgrade to sector perform from outperform by RBC Capital Markets. The stock on Tuesday recorded its biggest one-day loss in its history amid a sell-off in solar names. CERo Therapeutics Holdings — Stock in the immunotherapy company pulled back about 28%. On Tuesday, the U.S. Food and Drug Administration gave the company's acute myeloid leukemia drug CER-1236 an orphan drug designation .